Clinical utility of the interferon-γ release assay for elderly patients with active tuberculosis: A word of caution

Chest

Volumn 134, Issue 2, 2008, Pages 471-472

  Janssens, Jean Paul ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

AGED; ASSAY; CLINICAL ARTICLE; CYTOKINE RELEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DISEASE ACTIVITY; GERIATRIC PATIENT; HUMAN; INFECTION RATE; INTERMETHOD COMPARISON; LETTER; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; PRIORITY JOURNAL; PROBABILITY; TUBERCULIN TEST; TUBERCULOSIS; VERY ELDERLY;

EID: 49449100919     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.08-0434     Document Type: Letter

References (6)

1. Kobashi Y, Mouri K, Yagi S, et al. Clinical utility of the QuantiFERON TB-2G test for elderly patients with active tuberculosis. Chest 2008; 133:1196-1202
2. Mori T, Sakatani M, Yamagishi F, et al. Specific detection of tuberculosis infection: an interferon-γ-based assay using new antigens. Am J Respir Crit Care Med 2004; 170:59-64
3. Janssens JP, Roux-Lombard P, Perneger T, et al. Quantitative scoring of an interferon-γ assay for differentiating active from latent tuberculosis. Eur Respir J 2007; 30:722-728
4. Rieder HL. Epidemiological basis of tuberculosis control. Paris, France: International Union Against Tuberculosis and Lung Disease, 1999
5. Mazurek GH, Jereb J, Lobue P, et al. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 2005; 54(RR-15):49-55
6. Mayer D. Bayes' theorem and predictive values. In: Essential evidence-based medicine. Cambridge, UK: Cambridge University Press, 2004; 222-236